A new Report by Delvens, titled "Maternal Health market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global Maternal Health market size was estimated at USD 23.76 billion in 2023 and is projected to reach USD 61.30 billion in 2030 at a CAGR of 14.50% during the forecast period 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/maternal-health-market
Maternal Health refers to the health of women during pregnancy, childbirth, and the postpartum period. It encompasses the physical, mental and social wellbeing of women during these times. Maternal health is important because it affects the health of both the mother and the baby.
There are several factors that can affect maternal health such as age of the mother, socioeconomic status, location, access to healthcare, lifestyle choices. Maternal Health is a global issue in which, every year, millions of women die from preventable causes related to pregnancy and childbirth. However, there has been progress in recent years. The Maternal Mortality Ratio (MMR) has fallen by 45% since 1990.
Regional Analysis
Asia Pacific to Dominate the Market
Asia Pacific is estimated to account for the largest market share during the forecast period. This is due to a number of factors such as parents’ increased willingness to consult super specialists, the expansion of region’s developed healthcare infrastructure, and ongoing research efforts for the development of cutting-edge technology and services.
China’s maternal health market heled the largest share within the region in 2022, whereas India’s maternal health market is expected to rapidly grow during the forecast period.
Competitive Landscape
• Johnson & Johnson Private Limited
• Jiovio Healthcare
• McKesson Corporation
• MedTech Boston
• Merck & Co., Inc.
• RAND Corporation
• SYNAPSE Product Development
• International Federation of Pharmaceutical Manufacturers & Associations
• Siemens
• Agile Therapeutics and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/maternal-health-market
The Report helps to identify the opportunities in Global Regions:
• North America (the United States, Canada, and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
• South America (Brazil etc.)
• The Middle East and Africa (North Africa and GCC Countries)
Recent Developments
• In May 2022, Mirvie raised a total of USD 90 million following the closing of its series B funding. The funding encouraged Mirvie’s continued clinical and commercial development of the proprietary Mirvie RNA platform, which is the first to predict preeclampsia and preterm birth months before they happen by revealing the underlying biology of each pregnancy.
• In April 2022, A new prenatal test, called STORK (Short-read Transpore Rapid Karyotyping), was developed by researchers at Columbia University Fertility Center that can determine if a fetus or embryo has the right number of chromosomes at a fraction of the time and cost of currently available clinical genetic tests. The test can be used in the doctor’s office at the point of care, delivers results in under two hours, and is about 10 times less expensive to process per sample than current tests.
Table of Contents
The Maternal Health Market is segmented into various segments such as Type, Type of Pregnancy, Risks in pregnancy, complication, delivery type, care and region:
Based on Type
• Hormones
• Nutritives
• Analgesics
• Anti-Infectives
• Others
Based on the Type of Pregnancy
• Intrauterine
• Ectopic
• Tubal
• Others
Based on the Complication
• Miscarriage
o Threatened
o Inevitable
o Complete
o Incomplete
• Premature Labour and Birth
• Preeclampsia
• Gestational Diabetes
• Placenta Previa
• Others
Based on the Risks of Pregnancy
• High
• Molar
Based on the Delivery type
• Vaginal Delivery
• Caesarean Section
• Vacuum Extraction
• Forceps Delivery
Based on the Care
• Pre-Natal Care
• Post Natal Care
Access Full Report: https://www.delvens.com/report/maternal-health-market
In addition to the market data for the Maternal Health Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
More Reports from Delvens:
Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.
Functional Service Provider (FSP) Market size is projected to reach a CAGR of 8.7% from 2023-2030.
Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
[email protected]